The arginine methylation-dependent interaction between METTL14 and SMN, along with the global reduction in cellular m6A levels observed in SMN knockdown cells and in SMA patient-derived fibroblasts, uncovers a novel molecular pathway that might underline the systematic aspects of SMA pathogenesis. Here, METTL14 is linked to proximal spinal muscular atrophy.